This website is intended for healthcare professionals only and contains promotional content.

Report an adverse event here
Link Logo

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.​

OPIOID-INDUCED CONSTIPATION (OIC)

Treatment

Basic advice in managing constipation is to maintain high dietary fibre content and ample fluid intake. A comprehensive review of the available literature on diagnosis and management of OIC has, however, reported that there is little available evidence on the effectiveness of these actions in treating opioid-induced constipation.1

European consensus guidelines on the management of OIC recommend that, as well as examining lifestyle factors, a review of concurrent medications should be undertaken to assess whether any of these could be exacerbating OIC. These include iron supplements, calcium channel blockers, anti-cholinergic agents, 5-Hydroxytryptamine (5-HT)3 receptor antagonists and diuretics. In some cases, switching the opioid being taken or changing the route of administration can be useful.2

Conventional first-line treatment for all types of constipation, including OIC, is laxative therapy.2 Laxatives can provide relief for some OIC sufferers, but more than half of patients don’t respond satisfactorily.3,4 

Patients and their healthcare providers may have different impressions of laxative effectiveness. In a 2016 observational study in patients with OIC, the proportion of agreement on the level of benefit and satisfaction from laxatives varied between patients and healthcare providers. Of the patients who reported "little to no benefit" of laxative treatment at baseline (n=305), 53% of their healthcare providers reported "moderate-to-complete satisfaction" with laxative treatment at baseline.

Expert opinion on the treatment of OIC with conventional laxatives

How effective are laxatives in treating OIC?

PAMORAs as a treatment option for OIC

Opioid antagonist drugs can be helpful in relieving the symptoms of OIC, however drugs such as naloxone cross the blood-brain barrier and so can compromise pain control. Opioid antagonist drugs that primarily block opioid receptors in the GI tract can relieve the symptoms of OIC without diminishing pain control. This class of drugs is known as peripherally acting mu-opioid receptor antagonists (PAMORAs).

In 2019, a European expert consensus statement on the pathophysiology and management of opioid-induced constipation was published, suggesting a pragmatic, management algorithm for clinical practice.

View the European expert consensus statement

For advice on the responsible use of opioids to treat pain, please click here

Average:

  • References

    1. Drewes AM et al. Scand J Pain. 2016;11:111-122.

    2. Farmer AD et al. UEG Journal. 2019;7(1):7-20.

    3. Pappagallo M. Am J Surg. 2001; 182(5A Suppl):11S-18S.

    4. Brock C et al. Drugs. 2012; 72:1847-1865.

    5. LoCasale RJ et al. J Manag Care Spec Pharm. 2016;22(3):236-45.

    KKI/INT/KKI/0612 November 2023